A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection

NCT02391805 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Entecavir
DRUG: Placebo
DRUG: RO6864018
DRUG: Tenofovir

Sponsor

Hoffmann-La Roche